Business Description
Dallah Healthcare Co
ISIN : SA135G51UI10
Description
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Services/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.62 | |||||
| Debt-to-EBITDA | 3.13 | |||||
| Interest Coverage | 4.96 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.47 | |||||
| Beneish M-Score | -2.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.4 | |||||
| 3-Year EBITDA Growth Rate | 27.5 | |||||
| 3-Year EPS without NRI Growth Rate | 50.1 | |||||
| 3-Year FCF Growth Rate | 75.7 | |||||
| 3-Year Book Growth Rate | 18 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.73 | |||||
| 9-Day RSI | 25.89 | |||||
| 14-Day RSI | 31.85 | |||||
| 6-1 Month Momentum % | 15.93 | |||||
| 12-1 Month Momentum % | 4.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 0.96 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 45.91 | |||||
| Days Sales Outstanding | 93.08 | |||||
| Days Payable | 49.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.23 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| 3-Year Dividend Growth Rate | 11.5 | |||||
| Forward Dividend Yield % | 1.23 | |||||
| 5-Year Yield-on-Cost % | 1.73 | |||||
| 3-Year Average Share Buyback Ratio | -2.8 | |||||
| Shareholder Yield % | 1.14 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.65 | |||||
| Operating Margin % | 17.55 | |||||
| Net Margin % | 12.24 | |||||
| FCF Margin % | 11.18 | |||||
| ROE % | 12.3 | |||||
| ROA % | 6.12 | |||||
| ROIC % | 9.21 | |||||
| ROC (Joel Greenblatt) % | 14.07 | |||||
| ROCE % | 10.32 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 44.11 | |||||
| Forward PE Ratio | 37.74 | |||||
| PE Ratio without NRI | 41.4 | |||||
| Shiller PE Ratio | 59.26 | |||||
| Price-to-Owner-Earnings | 54.08 | |||||
| PEG Ratio | 1.88 | |||||
| PS Ratio | 5.4 | |||||
| PB Ratio | 4.98 | |||||
| Price-to-Tangible-Book | 5.27 | |||||
| Price-to-Free-Cash-Flow | 48.36 | |||||
| Price-to-Operating-Cash-Flow | 25.43 | |||||
| EV-to-EBIT | 34.81 | |||||
| EV-to-EBITDA | 27.87 | |||||
| EV-to-Revenue | 5.97 | |||||
| EV-to-Forward-Revenue | 5.6 | |||||
| EV-to-FCF | 53.72 | |||||
| Price-to-Projected-FCF | 3.18 | |||||
| Price-to-DCF (Earnings Based) | 3.27 | |||||
| Price-to-DCF (FCF Based) | 1.54 | |||||
| Price-to-Median-PS-Value | 1.12 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.64 | |||||
| Price-to-Graham-Number | 3.1 | |||||
| Earnings Yield (Greenblatt) % | 2.87 | |||||
| FCF Yield % | 2.07 | |||||
| Forward Rate of Return (Yacktman) % | 21.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dallah Healthcare Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 2,942.898 | ||
| EPS (TTM) (ï·¼) | 3.7 | ||
| Beta | 0 | ||
| Volatility % | 32.55 | ||
| 14-Day RSI | 31.85 | ||
| 14-Day ATR (ï·¼) | 4.482984 | ||
| 20-Day SMA (ï·¼) | 168.04 | ||
| 12-1 Month Momentum % | 4.59 | ||
| 52-Week Range (ï·¼) | 131.4 - 194 | ||
| Shares Outstanding (Mil) | 97.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dallah Healthcare Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dallah Healthcare Co Stock Events
| Event | Date | Price(ï·¼) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dallah Healthcare Co Frequently Asked Questions
What is Dallah Healthcare Co(SAU:4004)'s stock price today?
The current price of SAU:4004 is ï·¼162.00. The 52 week high of SAU:4004 is ï·¼194.00 and 52 week low is ï·¼131.40.
When is next earnings date of Dallah Healthcare Co(SAU:4004)?
The next earnings date of Dallah Healthcare Co(SAU:4004) is .
Does Dallah Healthcare Co(SAU:4004) pay dividends? If so, how much?
The Dividend Yield %  of Dallah Healthcare Co(SAU:4004) is 1.23% (As of Today), Highest Dividend Payout Ratio of Dallah Healthcare Co(SAU:4004) was 1.66. The lowest was 0.27. And the median was 0.54. The  Forward Dividend Yield % of Dallah Healthcare Co(SAU:4004) is 1.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers